Cybin (HELP) Long-Term Investments (2021 - 2022)
Cybin's (HELP) quarterly Long-Term Investments came in at $92087.9 in Q4 2022, down 53.57% YoY from $198334.0 in Q4 2021, and down 56.8% on a QoQ basis from $213155.5 in Q3 2022.
Cybin (HELP) Long-Term Investments (2021 - 2022) Analysis & Trends
Cybin (HELP) has 2 years of Long-Term Investments data on file, last reported at $92087.9 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 92,087.87 |
| Sep 30, 2022 | 213,155.46 |
| Dec 31, 2021 | 198,334.02 |
| Sep 30, 2021 | 198,602.33 |
| Jun 30, 2021 | 203,381.79 |